Literature DB >> 15980614

The mouse model for scrapie: inoculation, clinical scoring, and histopathological techniques.

Harry C Meeker1, Xuemin Ye, Richard I Carp.   

Abstract

The mouse is a popular and versatile model for the study of scrapie and other transmissible spongiform encephalopathies. In this chapter, information is given for preparation of infectious material for inoculation and a method of clinical scoring that yields accurate and reproducible quantification of the scrapie incubation period. With the help of histopathological and immunopathological techniques, we can detect brain pathological changes in scrapie-infected animals at the cellular and molecular level. We will also describe the histological and immunocytochemistry methods we use for scrapie research, outline step-by-step procedures, discuss tissue preparation, fixation, and processing of specimens, and provide special hints to achieve successful staining. We also include our results of PrPSc and GFAP immunostaining in scrapie research. In conclusion, immunopathological staining is an important and useful tool in the research of scrapie pathology.

Entities:  

Mesh:

Year:  2005        PMID: 15980614     DOI: 10.1385/1-59259-874-9:309

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

1.  Therapeutic activity of inhibition of the soluble epoxide hydrolase in a mouse model of scrapie.

Authors:  Giorgio Poli; Erica Corda; Piera Anna Martino; Paola Dall'ara; Silvio R Bareggi; Giampietro Bondiolotti; Barbara Iulini; Maria Mazza; Cristina Casalone; Sung Hee Hwang; Bruce D Hammock; Bora Inceoglu
Journal:  Life Sci       Date:  2013-05-05       Impact factor: 5.037

2.  Therapeutic effect of CHF5074, a new γ-secretase modulator, in a mouse model of scrapie.

Authors:  Giorgio Poli; Erica Corda; Barbara Lucchini; Maria Puricelli; Piera Anna Martino; Paola Dall'ara; Gino Villetti; Silvio R Bareggi; Cristiano Corona; Elena Vallino Costassa; Paola Gazzuola; Barbara Iulini; Maria Mazza; Pierluigi Acutis; Paolo Mantegazza; Cristina Casalone; Bruno P Imbimbo
Journal:  Prion       Date:  2012 Jan-Mar       Impact factor: 3.931

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.